Varian Medical Systems is the world's leading manufacturer of medical technology for treating cancer and other medical conditions with radiotherapy, brachytherapy, and radiosurgery. The company is also a premier supplier of X-ray tubes and digital image detectors for imaging in medical, scientific, and industrial applications.  The company's high energy imaging systems are also used for screening cargo.  Varian Medical Systems employs over 4,000 people who are located at manufacturing sites in North America, China, and Europe and in sales and support offices around the world. 

The company operates businesses in several areas: 

  • The Oncology Systems business is the world's leading supplier of radiotherapy products for treating cancer and other conditions, as well as informatics software for managing comprehensive cancer clinics. Its products include linear accelerators, simulators, proton therapy systems, and a broad range of accessories and interconnected software tools for planning, verifying, and delivering the most advanced radiation, radiosurgical, and brachytherapy treatments. Varian's BrachyTherapy operation is the technology leader in products used for treating cancer by temporarily inserting radiation sources within tumor sites. With its partner, BrainLab, Varian also produces technology for stereotactic radiosurgery and neurosurgery, for the treatment of cancer and other disorders of the central nervous system. 
  • The X-ray Products business is the world’s premier independent supplier of X-ray tubes and flat-panel X-ray image detectors for X-ray imaging. Its products are used in X-ray imaging equipment for medical diagnostics, dental imaging, veterinary care, industrial inspection, and security.
  • The Security and Inspection Products Group is the market leader in high-energy X-ray devices for non-destructive testing and cargo screening.
Corporate Communications Contacts
Spencer Sias
Vice President, Corporate Communications and Investor Relations
Meryl Ginsberg
Director, Public Relations
Neil Madle
Director, Corporate Communications/Investor Relations, Europe
+44 (0)7786 526 068

more ›

Subscribe to News Alerts

Print Normal Bigger Large